The medical device sector in India is recognized as a sunrise sector because of its immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities, as...
Lipocine Inc., a biopharmaceutical company utilizing its own technology platform to enhance therapeutics via efficient oral delivery, reported that the US Food and Drug Administration (FDA) has awarded Fast Track Designation to LPCN 1148 for...
India's pharmaceutical sector, ranked as the third largest in the world by volume, was valued at $50 billion in the fiscal year 2023-24, as per Union Minister of State for Chemicals and Fertilizers Anupriya Patel. The domestic consumption value of...
The secondary packaging market for biologics CDMO is undergoing considerable expansion owing to the rising incidence of chronic illnesses globally. As chronic diseases become more common, the necessity for novel therapies and precision medicine...
Merck announced that the US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for clesrovimab (MK-1654), the company's experimental long-acting monoclonal antibody aimed at safeguarding infants from...
Supriya Lifescience's new plant is anticipated to improve production capabilities, aiding its expansion in the competitive pharmaceutical sector. Pharma shares experienced a 6 percent rise after the launch of a modern E-Production Block in...
The market for AI in clinical trials is fueled by the significant rate of clinical trial failures, the growing demand for predicting drug pharmacokinetics, pharmacodynamics, and toxicity management. The worldwide market for artificial intelligence...
Smith+Nephew, the worldwide medical technology firm, announces it has obtained 510(k) authorization from the United States Food & Drug Administration for a stemless anatomical total shoulder for the AETOS Shoulder System (AETOS Stemless). AETOS...
China is the biggest market for data and analytics in the pharmaceutical industry, accounting for about 20.2% of worldwide sales in 2022, rising to 25.9% by 2028. The global data and analytics market in pharmaceuticals is projected to grow at a...
The PLI scheme will enhance resilience against external shocks, strengthen drug security, and increase the ability to produce critical bulk drugs and higher-value products domestically. The three support schemes revealed by the government will...
, CDSCO.jpg)
